RD514 - Report on the Specialty Drug Program – November 2016


Executive Summary:
The 2016 Appropriation Act, Item 306 (S5), requires:

“The department shall report on savings and quality improvements achieved through the implementation measures for the specialty drug program to the Chairmen of the House Appropriations and Senate Finance Committees, the Joint Commission on Health Care, and the Department of Planning and Budget by November 1 of each year.”

This report responds to the requirement in Item 306 (S) (5) that the Department annually report on the cost savings and quality improvements achieved through the program.